|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.981
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.978
|
|
|
|
intrinsic apoptotic signaling pathway by p53 class mediator
|
GO:0072332 |
35 |
0.967
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.965
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.949
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.920
|
|
|
|
cell cycle arrest
|
GO:0007050 |
37 |
0.882
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.842
|
|
|
|
signal transduction by p53 class mediator
|
GO:0072331 |
51 |
0.841
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.836
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.825
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.799
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.792
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.785
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.749
|
Human Mouse |
|
|
segmentation
|
GO:0035282 |
93 |
0.743
|
|
|
|
regulation of synaptic plasticity
|
GO:0048167 |
87 |
0.671
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.666
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.661
|
Human |
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.656
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.632
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.631
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.628
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.608
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.606
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.601
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.598
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.596
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.591
|
Human |
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.591
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.579
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.563
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.558
|
Human Mouse |
|
|
axonogenesis
|
GO:0007409 |
274 |
0.550
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.536
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.522
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.506
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.502
|
Human |
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.502
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.498
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.495
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.494
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.491
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.491
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.486
|
|
|
|
dna recombination
|
GO:0006310 |
92 |
0.484
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.481
|
Human Mouse |
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.468
|
|
|
|
carbon catabolite activation of transcription
|
GO:0045991 |
4 |
0.467
|
|
|
|
collagen fibril organization
|
GO:0030199 |
32 |
0.464
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.452
|
Human |
|
|
positive regulation of peptidyl tyrosine phosphorylation
|
GO:0050731 |
61 |
0.446
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.440
|
|
|
|
odontogenesis of dentin containing tooth
|
GO:0042475 |
66 |
0.436
|
|
|
|
jnk cascade
|
GO:0007254 |
72 |
0.429
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.428
|
|
|
|
oocyte differentiation
|
GO:0009994 |
35 |
0.427
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.427
|
|
|
|
mitotic g1 dna damage checkpoint
|
GO:0031571 |
4 |
0.424
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.419
|
|
|
|
oocyte axis specification
|
GO:0007309 |
2 |
0.418
|
|
|
|
epithelial cell maturation involved in prostate gland development
|
GO:0060743 |
4 |
0.415
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.411
|
Human |
|
|
dna damage response signal transduction by p53 class mediator resulting in cell cycle arrest
|
GO:0006977 |
3 |
0.410
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.406
|
|
|
|
regulation of stress activated mapk cascade
|
GO:0032872 |
69 |
0.403
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.402
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.401
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
81 |
0.397
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.396
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.392
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.388
|
|
|
|
positive regulation of keratinocyte proliferation
|
GO:0010838 |
4 |
0.386
|
|
|
|
hippocampus development
|
GO:0021766 |
52 |
0.383
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.378
|
|
|
|
positive regulation of mitotic cell cycle
|
GO:0045931 |
41 |
0.362
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.362
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.358
|
|
|
|
pole plasm assembly
|
GO:0007315 |
2 |
0.355
|
|
|
|
regulation of cell division
|
GO:0051302 |
76 |
0.354
|
|
|
|
g1 s transition of mitotic cell cycle
|
GO:0000082 |
57 |
0.340
|
Mouse |
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.340
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.340
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.334
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.333
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.331
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.325
|
|
|
|
pyramidal neuron migration
|
GO:0021852 |
1 |
0.316
|
|
|
|
response to x ray
|
GO:0010165 |
11 |
0.315
|
|
|
|
intracellular signal transduction involved in g1 dna damage checkpoint
|
GO:1902400 |
3 |
0.314
|
|
|
|
positive regulation of extrinsic apoptotic signaling pathway via death domain receptors
|
GO:1902043 |
13 |
0.311
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.309
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.309
|
|
|
|
signal transduction involved in dna integrity checkpoint
|
GO:0072401 |
3 |
0.309
|
|
|
|
b cell differentiation
|
GO:0030183 |
78 |
0.306
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.305
|
|
|
|
columnar cuboidal epithelial cell differentiation
|
GO:0002065 |
82 |
0.303
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.303
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.302
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.300
|
|
|
|
signal transduction involved in dna damage checkpoint
|
GO:0072422 |
3 |
0.299
|
|
|
|
regulation of cell cycle arrest
|
GO:0071156 |
12 |
0.294
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.293
|
|
|
|
negative regulation of leukocyte differentiation
|
GO:1902106 |
51 |
0.293
|
|
|
|
negative regulation of cell cycle phase transition
|
GO:1901988 |
48 |
0.292
|
Human Mouse |
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.289
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.286
|
|
|
|
negative regulation of lymphocyte activation
|
GO:0051250 |
91 |
0.286
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.280
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.279
|
|
|
|
developmental programmed cell death
|
GO:0010623 |
41 |
0.277
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.275
|
Human |
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.275
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.275
|
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.273
|
|
|
|
retinal ganglion cell axon guidance
|
GO:0031290 |
18 |
0.270
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.269
|
|
|
|
endochondral bone morphogenesis
|
GO:0060350 |
50 |
0.269
|
|
|
|
regulation of erythrocyte differentiation
|
GO:0045646 |
23 |
0.269
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.268
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.266
|
|
|
|
nephron morphogenesis
|
GO:0072028 |
69 |
0.265
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.262
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.259
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.255
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.255
|
|
|
|
regulation of t cell differentiation
|
GO:0045580 |
83 |
0.254
|
|
|
|
carbon catabolite repression of transcription from rna polymerase ii promoter
|
GO:0000437 |
1 |
0.253
|
|
|
|
cellular senescence
|
GO:0090398 |
11 |
0.251
|
|
|
|
positive regulation of auditory receptor cell differentiation
|
GO:0045609 |
1 |
0.250
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.250
|
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
71 |
0.249
|
Human |
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.249
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.247
|
Human |
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.247
|
|
|
|
signal transduction involved in cell cycle checkpoint
|
GO:0072395 |
3 |
0.246
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.244
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.244
|
|
|
|
lung induction
|
GO:0060492 |
3 |
0.243
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.238
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.237
|
|
|
|
ureteric bud morphogenesis
|
GO:0060675 |
62 |
0.236
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.234
|
|
|
|
regulation of epithelial cell proliferation involved in prostate gland development
|
GO:0060768 |
10 |
0.231
|
|
|
|
meiosis i
|
GO:0007127 |
60 |
0.231
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.231
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.228
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.226
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.225
|
|
|
|
auditory receptor cell fate specification
|
GO:0042667 |
1 |
0.223
|
|
|
|
regulation of mitosis
|
GO:0007088 |
29 |
0.222
|
|
|
|
negative regulation of cellular catabolic process
|
GO:0031330 |
47 |
0.221
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.221
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.220
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.218
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.216
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.214
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.211
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.211
|
|
|
|
epithelium migration
|
GO:0090132 |
63 |
0.210
|
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
73 |
0.210
|
|
|
|
positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator
|
GO:1902255 |
2 |
0.208
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.206
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.206
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.205
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
93 |
0.204
|
|
|
|
oviduct development
|
GO:0060066 |
3 |
0.204
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.202
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.202
|
|
|
|
mesonephric tubule development
|
GO:0072164 |
94 |
0.202
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.199
|
|
|
|
negative regulation of mitotic cell cycle phase transition
|
GO:1901991 |
45 |
0.199
|
Human Mouse |
|
|
intrinsic apoptotic signaling pathway in response to dna damage
|
GO:0008630 |
57 |
0.198
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.197
|
Human |
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.196
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.196
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.196
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.196
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.195
|
|
|
|
regulation of peptide secretion
|
GO:0002791 |
77 |
0.192
|
|
|
|
negative regulation of fibroblast proliferation
|
GO:0048147 |
14 |
0.192
|
|
|
|
mitral valve development
|
GO:0003174 |
4 |
0.191
|
|
|
|
regulation of ras gtpase activity
|
GO:0032318 |
88 |
0.189
|
|
|
|
regulation of cell size
|
GO:0008361 |
72 |
0.188
|
|
|
|
signal transduction involved in mitotic dna damage checkpoint
|
GO:1902402 |
3 |
0.187
|
|
|
|
schwann cell proliferation
|
GO:0014010 |
2 |
0.187
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.186
|
|
|
|
neuroblast differentiation
|
GO:0014016 |
2 |
0.186
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter involved in norepinephrine biosynthetic process
|
GO:2000763 |
1 |
0.186
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.185
|
|
|
|
endothelial cell migration
|
GO:0043542 |
44 |
0.185
|
|
|
|
nephron tubule morphogenesis
|
GO:0072078 |
68 |
0.184
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.184
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.182
|
|
|
|
positive regulation of cell cycle process
|
GO:0090068 |
61 |
0.181
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.181
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
59 |
0.180
|
|
|
|
negative regulation of t cell proliferation
|
GO:0042130 |
38 |
0.179
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.179
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.179
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.178
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.177
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.177
|
|
|
|
regulation of protein stability
|
GO:0031647 |
52 |
0.177
|
|
|
|
somite development
|
GO:0061053 |
81 |
0.176
|
|
|
|
regulation of nucleocytoplasmic transport
|
GO:0046822 |
73 |
0.176
|
|
|
|
positive regulation of cell morphogenesis involved in differentiation
|
GO:0010770 |
72 |
0.175
|
|
|
|
carbon catabolite activation of transcription from rna polymerase ii promoter
|
GO:0000436 |
4 |
0.175
|
|
|
|
forebrain neuron development
|
GO:0021884 |
30 |
0.175
|
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
107 |
0.175
|
|
|
|
positive regulation of stem cell differentiation
|
GO:2000738 |
23 |
0.174
|
|
|
|
odontogenesis
|
GO:0042476 |
78 |
0.173
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.173
|
|
|
|
male gonad development
|
GO:0008584 |
88 |
0.172
|
|
|
|
positive regulation of neuron projection development
|
GO:0010976 |
79 |
0.172
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.172
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.172
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.172
|
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
77 |
0.171
|
Human Mouse |
|
|
limbic system development
|
GO:0021761 |
72 |
0.170
|
|
|
|
positive regulation of inner ear receptor cell differentiation
|
GO:2000982 |
1 |
0.169
|
|
|
|
auditory receptor cell fate determination
|
GO:0042668 |
3 |
0.169
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.167
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.166
|
|
|
|
somitogenesis
|
GO:0001756 |
69 |
0.166
|
|
|
|
activation of adenylate cyclase activity
|
GO:0007190 |
4 |
0.166
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.165
|
|
|
|
cardiac neural crest cell migration involved in outflow tract morphogenesis
|
GO:0003253 |
3 |
0.165
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.163
|
|
|
|
sprouting angiogenesis
|
GO:0002040 |
26 |
0.163
|
|
|
|
dna damage response signal transduction by p53 class mediator
|
GO:0030330 |
19 |
0.162
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.161
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.160
|
|
|
|
regulation of mast cell differentiation
|
GO:0060375 |
3 |
0.159
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.159
|
|
|
|
regulation of endocardial cushion to mesenchymal transition involved in heart valve formation
|
GO:2000800 |
1 |
0.157
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.157
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.157
|
|
|
|
nephron tubule development
|
GO:0072080 |
84 |
0.156
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.155
|
Human |
|
|
oogenesis
|
GO:0048477 |
56 |
0.155
|
|
|
|
paraxial mesodermal cell differentiation
|
GO:0048342 |
2 |
0.155
|
|
|
|
negative regulation of stem cell proliferation
|
GO:2000647 |
12 |
0.155
|
|
|
|
aortic valve morphogenesis
|
GO:0003180 |
4 |
0.153
|
|
|
|
meiotic cell cycle process
|
GO:1903046 |
77 |
0.152
|
|
|
|
stem cell division
|
GO:0017145 |
30 |
0.151
|
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.151
|
|
|
|
positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation
|
GO:2000802 |
1 |
0.151
|
|
|
|
tube closure
|
GO:0060606 |
91 |
0.151
|
|
|
|
notch signaling pathway
|
GO:0007219 |
71 |
0.150
|
|
|
|
lens development in camera type eye
|
GO:0002088 |
62 |
0.150
|
|
|
|
positive regulation of lymphocyte apoptotic process
|
GO:0070230 |
13 |
0.149
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.149
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.149
|
|
|
|
t cell differentiation in thymus
|
GO:0033077 |
77 |
0.148
|
|
|
|
negative regulation of nuclear division
|
GO:0051784 |
19 |
0.147
|
|
|
|
mesenchyme morphogenesis
|
GO:0072132 |
32 |
0.147
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.147
|
|
|
|
negative regulation of cell growth
|
GO:0030308 |
44 |
0.146
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.146
|
|
|
|
regulation of kidney development
|
GO:0090183 |
40 |
0.146
|
|
|
|
embryonic skeletal system morphogenesis
|
GO:0048704 |
91 |
0.144
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.144
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.143
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.143
|
|
|
|
phenol containing compound metabolic process
|
GO:0018958 |
60 |
0.143
|
|
|
|
regulation of actin filament bundle assembly
|
GO:0032231 |
18 |
0.142
|
|
|
|
regulation of stem cell differentiation
|
GO:2000736 |
50 |
0.141
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.141
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.141
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.140
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.139
|
|
|
|
tertiary branching involved in mammary gland duct morphogenesis
|
GO:0060748 |
3 |
0.139
|
|
|
|
oocyte construction
|
GO:0007308 |
2 |
0.138
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.138
|
|
|
|
regulation of transforming growth factor beta receptor signaling pathway
|
GO:0017015 |
43 |
0.137
|
Human |
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.136
|
Human |
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.136
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.135
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.134
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.134
|
|
|
|
regulation of cell cycle g1 s phase transition
|
GO:1902806 |
35 |
0.132
|
Mouse |
|
|
morphogenesis of a polarized epithelium
|
GO:0001738 |
37 |
0.130
|
|
|
|
positive regulation of epithelial cell proliferation involved in lung morphogenesis
|
GO:0060501 |
3 |
0.129
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.129
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.128
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.128
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.128
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.127
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.127
|
|
|
|
t cell selection
|
GO:0045058 |
34 |
0.127
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.127
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.126
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.126
|
|
|
|
regulation of rho gtpase activity
|
GO:0032319 |
58 |
0.126
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.126
|
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
73 |
0.125
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.124
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.122
|
|
|
|
planar cell polarity pathway involved in cardiac muscle tissue morphogenesis
|
GO:0061350 |
2 |
0.122
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.121
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.121
|
|
|
|
regulation of lymphocyte differentiation
|
GO:0045619 |
107 |
0.121
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.120
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.120
|
|
|
|
ovulation cycle
|
GO:0042698 |
59 |
0.120
|
|
|
|
actin filament bundle assembly
|
GO:0051017 |
40 |
0.120
|
|
|
|
kidney morphogenesis
|
GO:0060993 |
83 |
0.120
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
85 |
0.119
|
|
|
|
positive regulation of extrinsic apoptotic signaling pathway
|
GO:2001238 |
34 |
0.118
|
|
|
|
positive regulation of map kinase activity
|
GO:0043406 |
84 |
0.118
|
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.118
|
|
|
|
embryonic axis specification
|
GO:0000578 |
30 |
0.118
|
|
|
|
cardiac right ventricle formation
|
GO:0003219 |
3 |
0.117
|
|
|
|
positive regulation of chromosome organization
|
GO:2001252 |
33 |
0.117
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.116
|
|
|
|
fibroblast growth factor receptor signaling pathway
|
GO:0008543 |
46 |
0.116
|
|
|
|
maternal determination of anterior posterior axis embryo
|
GO:0008358 |
2 |
0.115
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.114
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.114
|
|
|
|
positive regulation of exit from mitosis
|
GO:0031536 |
1 |
0.113
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.113
|
|
|
|
negative regulation of cyclin dependent protein serine threonine kinase activity
|
GO:0045736 |
9 |
0.112
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.112
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.112
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.112
|
Human Mouse |
|
|
negative regulation of cell motility
|
GO:2000146 |
61 |
0.112
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.112
|
|
|
|
endocardial cushion to mesenchymal transition involved in heart valve formation
|
GO:0003199 |
4 |
0.111
|
|
|
|
heart formation
|
GO:0060914 |
16 |
0.111
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.110
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.110
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.110
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.110
|
|
|
|
negative regulation of cell cycle process
|
GO:0010948 |
69 |
0.109
|
Human Mouse |
|
|
digestive system development
|
GO:0055123 |
200 |
0.109
|
|
|
|
mammary gland morphogenesis
|
GO:0060443 |
54 |
0.109
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.109
|
|
|
|
female gamete generation
|
GO:0007292 |
74 |
0.108
|
|
|
|
positive regulation of camp biosynthetic process
|
GO:0030819 |
19 |
0.108
|
|
|
|
negative regulation of neuron apoptotic process
|
GO:0043524 |
92 |
0.107
|
|
|
|
embryonic digit morphogenesis
|
GO:0042733 |
56 |
0.107
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.107
|
|
|
|
female genitalia morphogenesis
|
GO:0048807 |
3 |
0.106
|
|
|
|
blood vessel endothelial cell migration
|
GO:0043534 |
23 |
0.106
|
|
|
|
oocyte development
|
GO:0048599 |
33 |
0.106
|
|
|
|
development of primary male sexual characteristics
|
GO:0046546 |
88 |
0.106
|
|
|
|
secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development
|
GO:0060528 |
4 |
0.105
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.105
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.105
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.105
|
|
|
|
cerebellum development
|
GO:0021549 |
77 |
0.104
|
|
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
68 |
0.104
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.104
|
|
|
|
canonical wnt signaling pathway involved in negative regulation of apoptotic process
|
GO:0044336 |
4 |
0.104
|
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
68 |
0.103
|
|
|
|
fibroblast proliferation
|
GO:0048144 |
35 |
0.102
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.102
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.102
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.101
|
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.101
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.101
|
|
|
|
signal transduction involved in mitotic cell cycle checkpoint
|
GO:0072413 |
3 |
0.101
|
|
|
|
hemangioblast cell differentiation
|
GO:0060217 |
1 |
0.101
|
|
|
|
megakaryocyte differentiation
|
GO:0030219 |
26 |
0.100
|
Human |
|
|
pancreatic pp cell fate commitment
|
GO:0003329 |
2 |
0.100
|
|
|
|
astrocyte fate commitment
|
GO:0060018 |
4 |
0.100
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.100
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.100
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
73 |
0.099
|
Human Mouse |
|
|
central nervous system neuron development
|
GO:0021954 |
67 |
0.099
|
|
|
|
phenol containing compound biosynthetic process
|
GO:0046189 |
21 |
0.099
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.099
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.099
|
|
|
|
cloacal septation
|
GO:0060197 |
2 |
0.098
|
|
|
|
response to endoplasmic reticulum stress
|
GO:0034976 |
53 |
0.098
|
|
|
|
negative regulation of odontogenesis
|
GO:0042483 |
3 |
0.097
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.097
|
|
|
|
neuroblast proliferation
|
GO:0007405 |
49 |
0.097
|
|
|
|
nephric duct formation
|
GO:0072179 |
4 |
0.097
|
|
|
|
regulation of histone modification
|
GO:0031056 |
56 |
0.096
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.096
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.096
|
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
93 |
0.096
|
|
|
|
pituitary gland development
|
GO:0021983 |
38 |
0.096
|
|
|
|
mitral valve morphogenesis
|
GO:0003183 |
4 |
0.096
|
|
|
|
regulation of chromatin organization
|
GO:1902275 |
57 |
0.095
|
|
|
|
positive regulation of semaphorin plexin signaling pathway involved in outflow tract morphogenesis
|
GO:2000764 |
1 |
0.095
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.095
|
|
|
|
regulation of rho protein signal transduction
|
GO:0035023 |
71 |
0.094
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.094
|
|
|
|
regulation of cyclin dependent protein serine threonine kinase activity
|
GO:0000079 |
16 |
0.094
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.094
|
|
|
|
negative regulation of epithelial cell proliferation involved in prostate gland development
|
GO:0060770 |
7 |
0.093
|
|
|
|
germ line stem cell division
|
GO:0042078 |
2 |
0.093
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.093
|
|
|
|
regulation of fibroblast proliferation
|
GO:0048145 |
34 |
0.092
|
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.092
|
|
|
|
female genitalia development
|
GO:0030540 |
14 |
0.091
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.091
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.091
|
|
|
|
visceral serous pericardium development
|
GO:0061032 |
2 |
0.091
|
|
|
|
negative regulation of neuron death
|
GO:1901215 |
98 |
0.091
|
|
|
|
positive regulation of mechanoreceptor differentiation
|
GO:0045633 |
1 |
0.091
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.090
|
|
|
|
apoptotic process involved in mammary gland involution
|
GO:0060057 |
4 |
0.090
|
|
|
|
protein kinase b signaling
|
GO:0043491 |
74 |
0.090
|
|
|
|
renal inner medulla development
|
GO:0072053 |
3 |
0.090
|
|
|
|
regulation of apoptotic process involved in outflow tract morphogenesis
|
GO:1902256 |
2 |
0.089
|
|
|
|
regulation of glial cell differentiation
|
GO:0045685 |
41 |
0.089
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.089
|
|
|
|
regulation of somitogenesis
|
GO:0014807 |
6 |
0.089
|
|
|
|
extrinsic apoptotic signaling pathway in absence of ligand
|
GO:0097192 |
55 |
0.089
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.088
|
|
|
|
neural crest cell development
|
GO:0014032 |
48 |
0.088
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.088
|
|
|
|
formation of primary germ layer
|
GO:0001704 |
77 |
0.088
|
|
|
|
neural crest cell migration
|
GO:0001755 |
32 |
0.087
|
|
|
|
neuron projection extension
|
GO:1990138 |
64 |
0.087
|
|
|
|
negative regulation of t cell activation
|
GO:0050868 |
65 |
0.087
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.087
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.087
|
|
|
|
signal transduction involved in mitotic g1 dna damage checkpoint
|
GO:0072431 |
3 |
0.086
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.086
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.086
|
|
|
|
regulation of chromatin modification
|
GO:1903308 |
57 |
0.085
|
|
|
|
forebrain generation of neurons
|
GO:0021872 |
63 |
0.085
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.085
|
|
|
|
regulation of morphogenesis of a branching structure
|
GO:0060688 |
53 |
0.085
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.085
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.084
|
|
|
|
regulation of muscle cell apoptotic process
|
GO:0010660 |
17 |
0.083
|
|
|
|
methylation
|
GO:0032259 |
134 |
0.083
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.083
|
|
|
|
tendon formation
|
GO:0035992 |
4 |
0.083
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.082
|
|
|
|
mesenchymal to epithelial transition
|
GO:0060231 |
12 |
0.082
|
|
|
|
negative regulation of transforming growth factor beta receptor signaling pathway
|
GO:0030512 |
26 |
0.082
|
|
|
|
response to hypoxia
|
GO:0001666 |
58 |
0.082
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter by glucose
|
GO:0000432 |
3 |
0.082
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.082
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.081
|
|
|
|
regulation of transcription from rna polymerase iii promoter
|
GO:0006359 |
2 |
0.081
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.081
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.080
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.080
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.079
|
|
|
|
regulation of tumor necrosis factor superfamily cytokine production
|
GO:1903555 |
50 |
0.079
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.079
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.079
|
|
|
|
nephron epithelium morphogenesis
|
GO:0072088 |
68 |
0.079
|
|
|
|
regulation of odontogenesis
|
GO:0042481 |
18 |
0.078
|
|
|
|
mesangial cell differentiation
|
GO:0072007 |
4 |
0.078
|
|
|
|
negative regulation of cell substrate adhesion
|
GO:0010812 |
16 |
0.078
|
|
|
|
positive regulation of reactive oxygen species metabolic process
|
GO:2000379 |
11 |
0.078
|
|
|
|
thyroid stimulating hormone secreting cell differentiation
|
GO:0060129 |
4 |
0.077
|
|
|
|
regulation of gliogenesis
|
GO:0014013 |
50 |
0.077
|
|
|
|
positive regulation of angiogenesis
|
GO:0045766 |
46 |
0.077
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.077
|
|
|
|
mesodermal cell differentiation
|
GO:0048333 |
22 |
0.077
|
|
|
|
carbon catabolite regulation of transcription
|
GO:0045990 |
4 |
0.076
|
|
|
|
negative regulation of dna replication
|
GO:0008156 |
4 |
0.076
|
|
|
|
negative regulation of mitotic cell cycle
|
GO:0045930 |
58 |
0.076
|
Human Mouse |
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.076
|
|
|
|
protein autophosphorylation
|
GO:0046777 |
61 |
0.076
|
|
|
|
positive regulation of histone modification
|
GO:0031058 |
28 |
0.076
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.075
|
Human |
|
|
negative regulation of map kinase activity
|
GO:0043407 |
34 |
0.075
|
|
|
|
somatic diversification of immunoglobulins involved in immune response
|
GO:0002208 |
36 |
0.075
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.075
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.075
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.075
|
|
|
|
regulation of translation
|
GO:0006417 |
71 |
0.075
|
|
|
|
extrinsic apoptotic signaling pathway via death domain receptors
|
GO:0008625 |
34 |
0.075
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
86 |
0.075
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.075
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.075
|
|
|
|
apoptotic process involved in development
|
GO:1902742 |
28 |
0.075
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.074
|
|
|
|
transdifferentiation
|
GO:0060290 |
1 |
0.074
|
|
|
|
cell aging
|
GO:0007569 |
35 |
0.074
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.074
|
|
|
|
positive regulation of cyclic nucleotide biosynthetic process
|
GO:0030804 |
24 |
0.074
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.074
|
|
|
|
artery development
|
GO:0060840 |
53 |
0.073
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.073
|
|
|
|
positive regulation of striated muscle cell apoptotic process
|
GO:0010663 |
3 |
0.073
|
|
